MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Ultrasonography Markers in Prodromal Parkinson’s Disease

    S. Secades Garcia, J. Perez, B. La Casa, A. Contreras, F. Grandas (MADRID, Spain)

    Objective: This study aims to investigate ultrasonography markers  as a potential imaging marker in prodromal Parkinson's disease, with the goal of identifying individuals at higher…
  • 2024 International Congress

    Cholinergic brain vulnerabilities associate with diabetic comorbidity in Parkinson disease

    G. Carli, P. Kanel, T. Brown, S. Roytman, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: We aim to explore differences in brain cholinergic nerve terminal integrity between Parkinson's disease (PD) patients with and without comorbid diabetes, utilizing a highly…
  • 2024 International Congress

    Morphology and Functional Connectivity of the Basolateral Amygdala and Rapid Eye Movement Sleep Behavior Disorder

    Z. Song, Z. Wang, B. Zhang, J. Pu (Hangzhou, China)

    Objective: To determine the correlation of BLA morphology and functional connectivity (FC) with severity of RBD. Background: Idiopathic rapid eye movement sleep behavior disorder (iRBD)…
  • 2024 International Congress

    Parkinson’s Disease-Related Pattern in isolated REM Sleep Behavior Disorder as a prodromal progression marker

    G. Carli, S. Meles, A. Dortmond, A. Janzen, E. Sittig, E. de Meyer, K. Leenders, W. Oertel (Groningen, Netherlands)

    Objective: To investigate expression of the PD-related pattern in 18F-FDG PET scans of iRBD patients longitudinally. Background: The Parkinson’s disease-related pattern (PDRP) might serve as…
  • 2024 International Congress

    Associations between Choroid Plexus and tau in Parkinson’s Disease

    Z. Wang, J. Li, C. Cai, C. Jiang, L. Zhao (Hangzhou, China)

    Objective: To investigate the associations between the choroid plexus (ChP) and protein indicators of Parkinson’s Disease (PD). Background: The ChP is the primary organ that…
  • 2024 International Congress

    Abnormal basal ganglia-related functional gradient in Parkinson’s disease

    L. Chen, L. Sun, M. Xia, T. Wu (Beijing, China)

    Objective: The aim of this research was to investigate the basal ganglia (BG)-related functional gradient alterations and the association between these brain dysfunctions and clinical…
  • 2024 International Congress

    A group of patients with multiple system atrophy (MSA) exhibit cardiac sympathetic dysfunction to the same extent as Parkinson’s disease (PD).

    R. Yokoyama, T. Yamamoto (Moroyama, Japan)

    Objective: Although there are cases of multiple system atrophy (MSA) with decreased MIBG, there has not been sufficient investigation into the proportion. Thus, we retrospectively…
  • 2024 International Congress

    Investigating the pathogenesis of GBA1-associated Parkinson’s disease using GBA1 isogenic iPSC lines

    Y. Chen, C. Chen, C. Ma, J. Lichtenberg, E. Hertz, T. Jong, R. Sam, Y. Li, S. Vrisjen, P. Vangheluwe, C. Blauwendraat, E. Sidransky (Bethesda, USA)

    Objective: We aim to explore the pathogenesis of GBA1-associated synucleinopathies and discern the gain- vs. loss-of-function hypotheses by genetically engineering GBA1 in an iPSC line derived…
  • 2024 International Congress

    Neuroprotective role of baicalein via autophagy mediated modulation of associated motor proteins in experimental animals of Parkinson disease

    D. Khatri, P. Naren (Hyderabad, India)

    Objective: To evaluate neuroprotective role of baicalein via autophagy mediated modulation of associated motor proteins in rotenone induced mice model of Parkinson disease. Background: Parkinson's…
  • 2024 International Congress

    Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

    G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)

    Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…
  • « Previous Page
  • 1
  • …
  • 433
  • 434
  • 435
  • 436
  • 437
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley